文献速递治疗药物监测与药物基因组学特殊人群用药

药物基因组学实施:当前进展与挑战

Implementation of pharmacogenomics: Where are we now?
PubMed 文献 · Br J Clin Pharmacol · 2022-12-16

本文综述药物基因组学(PGx)在临床实施中的现状,介绍PGx交付模式与评估方法、有临床意义的检测及相关药物,并以加拿大安大略省氟尿嘧啶类用药前DPYD基因分型的广泛实施为例,说明具备充分临床证据的PGx检测可成为新的患者照护标准,同时指出PGx研究缺乏多样性等障碍并展望未来方向。

要点

  • PGx检测成本与周转时间改善,推动临床使用增加
  • DPYD基因分型指导氟尿嘧啶类用药是可操作的范例
  • PGx研究人群多样性不足限制广泛推广

核心结论

  • PGx检测成本与周转时间显著改善后,临床使用正在增加,但广泛实施仍面临挑战。

研究设计与样本

  • 本文为综述,概述PGx交付模式与评估方法、有临床意义的PGx检测及相关药物,并以加拿大安大略省氟尿嘧啶类用药前DPYD基因分型广泛实施为例。

主要发现

  • PGx研究数十年间广泛开展,检测成本与周转时间已显著改善。
  • PGx研究缺乏多样性,且存在影响PGx检测广泛采纳的一般性局限。

关键数值与推荐

  • 有足够临床证据显示患者获益的可操作PGx检测(如氟尿嘧啶类用药前DPYD基因分型)可成为新的患者照护标准。

临床怎么用

  • 可参考加拿大安大略省模式,对使用氟尿嘧啶类的患者广泛实施预先行DPYD基因分型。

局限性

  • PGx研究缺乏多样性。
  • 存在影响PGx检测广泛采纳的一般性局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pharmacogenomics (PGx), examining the effect of genetic variation on interpatient variation in drug disposition and response, has been widely studied for several decades. However, as cost, as well as turnaround time associated with PGx testing, has significantly improved, the use of PGx in the clinical setting has been gaining momentum. Nevertheless, challenges have emerged in the broader clinical implementation of PGx. In this review, we will outline current models of PGx delivery and methodologies of evaluation, and discuss clinically relevant PGx tests and associated medications. Additionally, we will describe our approach for the broad implementation of pre-emptive DPYD genotyping in patients taking fluoropyrimidines in Ontario, Canada, as an example of clinically actionable PGx testing with sufficient clinical evidence of patient benefit that can become a new standard of patient care. We will highlight challenges associated with PGx testing, including a lack of diversity in PGx studies as well as general limitations that impact the broad adoption of PGx testing. Lastly, we examine the future of PGx, discussing new clinical targets, methodologies and analysis approaches.

来源:Br J Clin Pharmacol,查看原文。版权归原作者所有。

引用

  1. Medwid S, Kim RB. Implementation of pharmacogenomics: Where are we now? Br J Clin Pharmacol. 2022. PMID: 36366858. doi:10.1111/bcp.15591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。